Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Naphthalene derivative identified as HIV-1 inhibitor

April 14, 2005

Emtriva and Truvada set for Japanese launch

April 12, 2005

U.K. Government funding for phase III trial of PRO-2000

April 11, 2005

Takara Bio and MolMed sign AIDS gene therapy development agreement

April 11, 2005

Gilead Sciences' JTK-303 license agreement gets FTC clearance

April 11, 2005

Theratechnologies plans phase III trials for ThGRF

April 5, 2005

Dosing begins in phase I study of CCR5 mAb in HIV patients

April 5, 2005

Completion of enrollment for phase I HIV vaccine trial

March 29, 2005

Gilead signs JTK-303 licensing agreement

March 24, 2005

TAK-220 chosen as a clinical candidate for HIV-1 treatment

March 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
XPC-837 restores network dysfunction in Dravet syndrome models
BioWorld Science
Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...